Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats

The pathogenesis of hyperuricemia-induced chronic kidney disease is largely unknown. In this study, we investigated whether extracellular signal–regulated kinases1/2 (ERK1/2) would contribute to the development of hyperuricemic nephropathy (HN). In a rat model of HN induced by feeding mixture of ade...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Na, Xu, Liuqing, Shi, Yingfeng, Fang, Lu, Gu, Hongwei, Wang, Hongrui, Ding, Xiaoqiang, Zhuang, Shougang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464913/
https://www.ncbi.nlm.nih.gov/pubmed/28442634
http://dx.doi.org/10.18632/oncotarget.16995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464913/
https://www.ncbi.nlm.nih.gov/pubmed/28442634
http://dx.doi.org/10.18632/oncotarget.16995

Ejemplares similares